Semaglutide, Tirzepatide Linked to Small Increase in Eye Disorder Risk
Written by
American Journal Managed Care
Published
0
comments
0
min
There is a low but increased risk of optic nerve disorders in patients with type 2 diabetes prescribed semaglutide or tirzepatide, according to a large cohort study.